Alimera Sciences Inc (ALIM)

Last Year

05-Feb-22 -- 04-Feb-23

Time Period:

($1.14M) Net Amount

Buy:	0	--
Sell:	($1.14M)	$4.55

Company Sentiment

Drug Manufacturers - Major

Drugs

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

1

(3)

0

(2)

0

(1)

33

0

1

+1

0

+2

0

+3

Two Year Chart

05-Feb-21 -- 04-Feb-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Nov-22 5:16 PM View:	31-Oct-22 Grant $1.65K	Jones John Philip Chief Financial Officer		Alimera Sciences Inc - ALIM	3% 31.39K to 32.19K	0	0	--	--	Show Txns Hide Txns

02-Nov-22 5:05 PM View:	31-Oct-22 Grant $2.22K	Eiswirth Richard S Jr President and CEO Director		Alimera Sciences Inc - ALIM	1% 135.52K to 136.52K	0	0	--	--	Show Txns Hide Txns

02-Nov-22 5:11 PM View:	31-Oct-22 Grant $2.22K	Holland David Chief Marketing Officer & SVP		Alimera Sciences Inc - ALIM	3% 39.88K to 40.88K	0	0	--	--	Show Txns Hide Txns

10-Feb-22 9:11 PM View:	08-Feb-22 Market Sale ($1.14M)	Morgan Stanley 10% Owner		Alimera Sciences Inc - ALIM	(31%) 807.55K to 557.55K	0	($1.14M) (31%)	--	$4.55	Show Txns Hide Txns

10-Jan-23 4:29 PM View:	09-Jan-23 Grant 0	Skibsted Russell Chief Financial Officer & SVP		Alimera Sciences Inc - ALIM	100% 0 to 17.5K	0	0	--	--	Show Txns Hide Txns